Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria

被引:5
|
作者
Cosmas, Nanma T. [1 ]
Nimzing, Lohya [1 ,2 ]
Egah, Daniel [1 ,3 ]
Famooto, Ayo [4 ]
Adebamowo, Sally N. [5 ,6 ]
Adebamowo, Clement A. [4 ,5 ,6 ]
机构
[1] Univ Jos, Coll Hlth Sci, Dept Med Microbiol, Jos, Nigeria
[2] Univ Jos, Coll Hlth Sci, Dept Med Lab Sci, Jos, Nigeria
[3] Jos Univ, Dept Med Microbiol, Teaching Hosp, Jos, Nigeria
[4] Inst Human Virol Nigeria, Abuja, Nigeria
[5] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 West Redmond St, Baltimore, MD 21201 USA
[6] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, 660 West Redmond St, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
Age-specific; Prevalence; HPV; Adolescent girls; HPV vaccine introduction; Jos Nigeria; HUMAN-PAPILLOMAVIRUS INFECTION; EARLY SEXUAL DEBUT; RISK-FACTORS; FEMALES;
D O I
10.1186/s12879-022-07215-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose Knowledge of the prevalence of HPV infection among adolescent and early adult girls is essential to determining the best age for the introduction of HPV vaccine, monitoring vaccine efficacy, and giving insight into determinants of persistent high-risk HPV infection, a necessary cause of cervical cancer. Yet, there have been limited studies of HPV infection among adolescent and early adult girls in low-and-middle-income countries. Methods In this cross-sectional study, we randomly selected 205 girls, aged 9-20 years, from 10 schools in central Nigeria. We obtained informed consent and assent, collected data, and trained participants to self-collect vaginal samples using swab stick. We genotyped HPV using SPF10-DEIA/LiPA(25) and analyzed data using Stata 14 (R). Results The mean (SD) age of the girls was 14.9 (2.3) years. We found HPV in 13.2% of vaginal swabs. The earliest age at which anyHPV and hrHPV infections were detected was 10 and 12 years respectively. The prevalence of any HPV peaked at 16 and 17 years, hrHPV at 16 years, lrHPV at 17 and 18 years and multiple hrHPV 18 years of age. The prevalence of hrHPV infection was 1.5% among the 9-12 years age group, 2.9% among 13-16 years and 3.4% among 17-20 years old. The commonest hrHPV types detected were 52 (3.9%), 18 (1.5%) and 51 (2.4%). The most common lrHPV types was 6 (2.9%). Conclusion The prevalence of HPV infection in these urbanized young girls in Nigeria is high and commences after 9 years of age. HPV vaccination in this population should start at 9 years of age or younger to prevent the establishment of persistent HPV infection. Key Messages The prevalence of HPV was 13.2% among adolescent girls in Jos, North-Central Nigeria. The earliest age at vaginal HPV infection was 11 years of age. The most predominant hrHPV type in vaginal swab was HPV 52. These findings point to the need for introduction of HPV vaccine starting at 9 years of age among girls in Nigeria to give maximum protection.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Designing disorder: spatial ordering and ethno-religious conflicts in Jos metropolis, North-Central Nigeria
    Nnabuihe, Onyekachi E.
    Onwuzuruigbo, Ifeanyi
    PLANNING PERSPECTIVES, 2021, 36 (01) : 75 - 93
  • [22] Prevalence of hepatitis B virus infection among pregnant women in Jos, Nigeria
    Magaji, Francis Ajang
    Okolo, Mark Ojogba
    Hassan, Z.
    Shambe, Iornum H.
    Pam, Victor Chung
    Ocheke, Amaka Ngozi
    Yiltok, Esther S.
    Golit, Williams
    Anzaku, Stephen Ajen
    Daloek, Martins
    Ogwuche, Jerry
    Imade, Godwin E.
    Isichie, Christain
    Mutihir, Jsiah T.
    Oguche, Stephen
    Agbaji, Oche
    Musa, Jonah
    Sagay, Solomon Ateine
    Zoakah, A., I
    Cohn, Susan E.
    ANNALS OF AFRICAN MEDICINE, 2020, 19 (03) : 176 - 181
  • [23] Correlates and determinants of Early Infant Diagnosis outcomes in North-Central Nigeria
    Patrick Dakum
    Monday Tola
    Nta Iboro
    Chukwuemeka A. Okolo
    Olachi Anuforom
    Christopher Chime
    Sam Peters
    Jibreel Jumare
    Obinna Ogbanufe
    Aliyu Ahmad
    Nicaise Ndembi
    AIDS Research and Therapy, 16
  • [24] Correlates and determinants of Early Infant Diagnosis outcomes in North-Central Nigeria
    Dakum, Patrick
    Tola, Monday
    Iboro, Nta
    Okolo, Chukwuemeka A.
    Anuforom, Olachi
    Chime, Christopher
    Peters, Sam
    Jumare, Jibreel
    Ogbanufe, Obinna
    Ahmad, Aliyu
    Ndembi, Nicaise
    AIDS RESEARCH AND THERAPY, 2019, 16 (01)
  • [25] Adolescent pregnancy outcomes in Jos, North Central Nigeria: The roles of disclosure and social support systems
    Degge, Hannah M.
    Olorunsaiye, Comfort Z.
    Achema, Timothy A.
    Ubanyi, Tina O.
    Yada, Farida N.
    GLOBAL PUBLIC HEALTH, 2023, 18 (01)
  • [26] Prevalence and Factors Associated with Diabetic Peripheral Neuropathy in Ilorin, North-Central Nigeria
    Bello, Abiodun
    Wahab, Kolawole
    Sanya, Emmanuel
    NEUROLOGY, 2019, 92 (15)
  • [27] THE PREVALENCE OF OBESITY AND ITS EFFECT ON BLOOD PRESSURE CONTROL IN NORTH-CENTRAL NIGERIA
    Adamu, U.
    Abdullahi, A.
    Aliyu, M. Z.
    Gbate, F.
    Agboola, O. F.
    Edem, K. P.
    Umenze, I.
    Indogesit, I. O.
    JOURNAL OF HYPERTENSION, 2015, 33 : E396 - E396
  • [28] Staphylococcus aureus Prevalence and Antibiotic Susceptibility Profile in Anyigba, North-Central Nigeria
    Mofolorunsho, Charles Kehinde
    Ocheni, Monday
    Omatola, Cornelius Arome
    Agieni, Ashem Godwin
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2015, 11 (04) : 93 - 97
  • [29] Vulnerability to HIV infection among adolescent girls and young women in Nigeria
    Arije, Olujide O.
    Udoh, Ekerette E.
    Ijadunola, Kayode T.
    Afolabi, Olusegun T.
    Aransiola, Joshua O.
    Omoregie, Godpower
    Tomori-Adeleye, Oyebukola
    Ukeme-Edet, Obiarairiuku
    Fajemisin, Oluwole
    Alaba, Oluwatoyin
    Onayade, Adedeji A.
    VULNERABLE CHILDREN AND YOUTH STUDIES, 2021, 16 (03) : 267 - 278
  • [30] IMPLANON SUB-DERMAL IMPLANTS: A 10-MONTH REVIEW OF ACCEPTABILITY IN JOS, NORTH-CENTRAL NIGERIA
    Mutihir, J. T.
    Daru, P. H.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2008, 11 (04) : 320 - 323